NASDAQ:TRAX | Income Statement | First Tracks Biotherapeutics, Inc.

Complete source-backed income-statement history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$25.64M$34.94M-$34.94M$1.56M-$33.37M-$0.95-$0.9535,003,00035,003,000
2026-03-31$33.96M$52.81M-$52.81M$2.33M-$50.48M
2025-06-30$39.27M$45.9M-$45.9M$3.45M-$42.45M-$1.47-$1.4728,810,00028,810,000
2025-03-31$41.47M$51.28M-$51.28M$4.08M-$47.2M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.